Literature DB >> 17218929

Mifepristone treatment of chronic central serous chorioretinopathy.

Jared S Nielsen1, Robert N Weinreb, Lawrence Yannuzzi, Lee M Jampol.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17218929     DOI： 10.1097/IAE.0b013e3180316fd8

Source DB:  PubMed          Journal:  Retina        ISSN： 0275-004X            Impact factor:   4.256


× No keyword cloud information.
  6 in total

1.  Finasteride for chronic central serous chorioretinopathy.

Authors:  Farzin Forooghian; Annal D Meleth; Catherine Cukras; Emily Y Chew; Wai T Wong; Catherine B Meyerle
Journal:  Retina       Date:  2011-04       Impact factor: 4.256

Review 2.  Lack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and review.

Authors:  Y-R Chung; E J Seo; H M Lew; K H Lee
Journal:  Eye (Lond)       Date:  2013-11-08       Impact factor: 3.775

3.  Finasteride is effective for the treatment of central serous chorioretinopathy.

Authors:  E Moisseiev; A J Holmes; A Moshiri; L S Morse
Journal:  Eye (Lond)       Date:  2016-04-08       Impact factor: 3.775

4.  Oral Rifampin treatment for longstanding chronic central serous chorioretinopathy.

Authors:  Shiri Shulman; Dafna Goldenberg; Roy Schwartz; Zohar Habot-Wilner; Adiel Barak; Nurit Ehrlich; Anat Loewenstein; Michaella Goldstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-03-21       Impact factor: 3.117

Review 5.  Oral medications for central serous chorioretinopathy: a literature review.

Authors:  William Fusi-Rubiano; Habiba Saedon; Vijay Patel; Yit C Yang
Journal:  Eye (Lond)       Date:  2019-09-16       Impact factor: 3.775

6.  Central serous chorioretinopathy: a pathogenetic model.

Authors:  Antonio Caccavale; Filippo Romanazzi; Manuela Imparato; Angelo Negri; Anna Morano; Fabio Ferentini
Journal:  Clin Ophthalmol       Date:  2011-02-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.